FDA Adverse Event Injury Summary report: N

VENTAK PRIZM

MDR report key: 2041551 · Received April 6, 2011

Report

Report Number
2124215-2011-01079
Event Type
Injury
Date Received
April 6, 2011
Date of Event
November 3, 2010
Report Date
February 10, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

UPON ANALYSIS, THIS EVENT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY THE VENTAK PRIZM DR HE ERI CAN BE TRIPPED EITHER BY VOLTAGE OR CHARGE TIME. ANALYSIS CONFIRMED THAT THE ERI TIMESTAMP WAS TRIPPED BY CHARGE TIME, RATHER THAN BATTERY VOLTAGE. LABORATORY TESTING ALSO REVEALED THAT THE BATTERY CELL IN THIS DEVICE HAD SUFFICIENT CAPACITY REMAINING, BUT HAD AN EXCESSIVE BUILD-UP OF INTERNAL IMPEDANCE THAT WAS HIGHER THAN ALLOWED FOR BY DESIGN. THIS RESULTED IN THE DEVICE'S INABILITY TO UTILIZE ALL AVAILABLE BATTERY CAPACITY.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) TRIGGERED ELECTIVE REPLACEMENT INDICATOR (ERI) AND WAS REPLACED. PREMATURE BATTERY DEPLETION WAS ALLEGED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VENTAK PRIZM IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND 1853

Patients

Seq Age Sex Outcome Treatment
1